Business Context and Reporting Period
Company: OptimizeRx Corporation (OPRX)
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2025
Reporting Period: First Quarter ended March 31, 2025
Context: The filing announces the issuance of a press release detailing financial results for the first quarter of 2025. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references the financial results but does not contain the specific numerical data within the filing text itself. Consequently, the following metrics are not available in the source document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing text does not contain management commentary, forward-looking guidance, or outlook statements.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 12, 2025) for actual Q1 2025 financial figures.
- Verify the specific revenue, net income, and cash position numbers which are not present in the 8-K cover page.
- Check for any forward-looking statements or updated guidance contained within the referenced press release.
- Confirm the trading symbol (OPRX) and exchange (Nasdaq Capital Market) for accurate market data retrieval.